United Kingdom news - the latest biotech news from Labiotech.eu

Home United Kingdom Page 61

Latest Posts

oxitec brazil mosquito gmo vector control zika dengue malaria city

News and Trends 14 Jul 2016

UPDATE: Brazilian city to be first in World to deploy GM Mosquitos against Dengue Fever

Oxitec‘s genetically engineered Mosquito trial is being expanded in Brazil’s Piracicaba region, to cover a city of over 60,000 people. With support from Ministry officials and the WHO, this UK biotech is making serious progress with their transgenic organism solution for Infectious diseases. UPDATE: (Article originally published 3/06/16). Just announced (14/07/16): The results from the trial […]

July 14, 2016 - 4 minutesmins - By Dani Bancroft

HIV diagnostic helen lee epo biotech inventor europe samba

News and Trends 12 Jul 2016

How did Helen Lee overcome barriers to HIV Diagnostics in the ‘Real World’?

How can diagnostics be improved in resource limited settings? And how can the practical limitations of transporting heat-sensitive assay material through hot climates be overcome? The University of Cambridge’s Dr Helen Lee won this year’s ‘Popular Choice’ Award, at the European Patent Office (EPO) awards. The winner of this prize category is selected from 15 other […]

July 12, 2016 - 6 minutesmins - By Dani Bancroft

charles darwin bristol graffiti origin species bioart simon park e1467992003422

News and Trends 9 Jul 2016

Bio-printing Clothes and Darwin’s book ‘On the Origin of Species’ with Bacteria

Simon Park is a professor at the University of Surrey in the UK who created the first book to be ‘printed’ with living bacteria, whereas Suzanne Lee is a New York based designer who uses the same species of bacteria in her clothing designs. This is probably one of the most unusual tributes to Charles Darwin, the English naturalist and geologist […]

July 9, 2016 - 4 minutesmins - By Joachim Eeckhout

failure biotech clinical trials june

News and Trends 6 Jul 2016

June was a Tough Month for European Biotech… #Fail

Abivax, Celyad, Circassia and Genticel – these are all European Biotechs that took a hit after failing key clinical trials in June. How are they doing now? Four different public Biotechs suffered setbacks in some of their advanced clinical trials. And, as always, the words ‘failed to meet primary endpoint‘ weren’t very popular with investors… […]

July 6, 2016 - 3 minutesmins - By Denise Neves Gameiro

deskgen desktop genetics biotech labiotech refresh crispr

News and Trends 5 Jul 2016

“CRISPR is highly fragmented, with too many approaches. We bring it all together”

The problem with CRISPR, is that not many people are actually experts in the field, and there are only a select few who worked on it pre-2013. So how did this UK Startup make a big name for itself in field of the ‘Biotech Breakthrough of the Century’? Desktop Genetics is a startup founded in 2012 by three […]

July 5, 2016 - 4 minutesmins - By Dani Bancroft

leo pharma astrazeneca dermatology biologics

News and Trends 4 Jul 2016

Danish Pharma enters in the Biologics arena with Antibody Buy-out

Leo Pharma is acquiring rights to two of AstraZeneca‘s candidates. The targeted indications are atopic dermatitis and psoriasis – autoimmune conditions getting more and more attention. Based near Copenhagen (Denmark), Leo Pharma specializes in dermatological therapies – particularly topical treatments. The company is not shy about its acquisitions, having entered a €675M deal to buy Japanese […]

July 4, 2016 - 3 minutesmins - By Denise Neves Gameiro

ADVERTISEMENT

uk biohackathon cambridge cutec 2016 biohacking alpha brick

News and Trends 4 Jul 2016

What kind of Startups were born at the UK’s First Biohackathon?

Organised by the University of Cambridge Technology and Enterprise Club (a catchy ‘CUTEC’ for short), the Biohackathon was the first of its kind organised in the UK… With SynBio veterans such as Bento Bio (inventors of the ‘Lunch box sized Laboratory’ for hackers, schools and DIY enthusiasts), Synthace (which invented Antha – ‘the programming language of […]

July 4, 2016 - 5 minutesmins - By Dani Bancroft

bristol myers squibb immunooncology cancer opdivo psioxus

News and Trends 1 Jul 2016

BMS to combine Immuno-Oncology Blockbuster with Oxford Biotech

Oxfordshire based PsiOxus will team up with the Immuno-Oncology Giant, Bristol-Myers Squibb, to test the combinatorial effect of their blockbuster drug with an Oncolytic viral therapy in late-stage cancer patients. Together they will evaluate the safety, tolerability, and preliminary efficacy of PsiOxus’ Enadenotucirev, a systemically administered oncolytic adenovirus therapeutic, in combination with Bristol-Myers Squibb’s Opdivo blockbuster (nivolumab), which […]

July 1, 2016 - 3 minutesmins - By Dani Bancroft

biotech discuva cambridge drug discovery brexit header

News and Trends 1 Jul 2016

Drug-resistant Bacteria should fear Discuva’s antimicrobials

Duty calls on the Island of Queen Elizabeth II…. What will be the future of Biotech in the United Kingdom and in Europe? Last week we did a review to catch up with all the details of #Brexit and this is why we decided to head up to Cambridge, one of the major biotech and research centers in the […]

July 1, 2016 - 2 minutesmins - By Joachim Eeckhout

red algae global warming bioalbedo gfz potsdam

News and Trends 24 Jun 2016

Why would Snow-growing Algae be killing Glaciers?

Red Algae bloom on glaciers during summer, which may give the snow more than a nice pink shade. The darker color makes the glacier melt faster – a previously overlooked mechanism in climate change. In biotech, algae almost became synonymous with unlimited potential, including as a promising new generation of biofuels – so they should be pretty environment-friendly, right? […]

June 24, 2016 - 3 minutesmins - By Denise Neves Gameiro

brexit uk biotech scene

News and Trends 24 Jun 2016

#Brexit: Sad news for the UK Biotech scene…

The first thing I checked this morning was the outcome of the Brexit vote, and what sad news when I read Brexit won. It was close, but the only thing that matters is the end result. Now, what will be the impact of such a vote on the UK biotech scene? The result will be significant, […]

June 24, 2016 - 5 minutesmins - By Joachim Eeckhout

f2g fungal infections antifungals aspergillosis

News and Trends 22 Jun 2016

Massive Round: Novel Antifungals get €53M from Top-Notch Investors

F2G has raised €53M to advance its news class of treatments for life-threatening fungal infections, including invasive aspergillosis. The technology has attracted some of the major biotech investors in Europe. Based in Manchester (UK), F2G focuses on developing therapies for invasive fungal infections such as aspergillosis. This type of infections mostly affect patients that are […]

June 22, 2016 - 2 minutesmins - By Denise Neves Gameiro

ADVERTISEMENT